Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.06 USD 1.48% Market Closed
Market Cap: 18.5m USD

Wall Street
Price Targets

VVOS Price Targets Summary
Vivos Therapeutics Inc

Wall Street analysts forecast VVOS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VVOS is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.04 USD
96% Upside
Average
Price Target
5.61 USD
172% Upside
Highest
Price Target
7.35 USD
257% Upside
Vivos Therapeutics Inc Competitors:
Price Targets
ADUS
Addus Homecare Corp
32% Upside
V3V
Vita 34 AG
28% Upside
4544
H.U. Group Holdings Inc
11% Upside
HIMS
Hims & Hers Health Inc
40% Upside
ALPHA
Alpha IVF Group Bhd
48% Upside
AHX
Apiam Animal Health Ltd
2% Upside
TALK
Talkspace Inc
39% Upside
PRDA
Prodia Widyahusada Tbk PT
24% Upside

Revenue
Forecast

Revenue Estimate
Vivos Therapeutics Inc

For the last 5 years the compound annual growth rate for Vivos Therapeutics Inc's revenue is 6%. The projected CAGR for the next 2 years is 35%.

6%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vivos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Vivos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VVOS's stock price target?
Price Target
5.61 USD

According to Wall Street analysts, the average 1-year price target for VVOS is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

What is Vivos Therapeutics Inc's Revenue forecast?
Projected CAGR
35%

For the last 5 years the compound annual growth rate for Vivos Therapeutics Inc's revenue is 6%. The projected CAGR for the next 2 years is 35%.

Back to Top